Abstract
No public abstract is available from the verified source records.
Doo Sun Sim, Myung Ho Jeong
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Position statement on antiplatelet therapy for East Asians with coronary artery disease: 2025 update
10.1016/j.jacasi.2025.04.010 · 2025
Twenty-year clinical experience of the Korea acute myocardial infarction registry
10.4070/kcj.2025.0360 · 2025
Current status of acute myocardial infarction in Korea
10.3904/kjim.2018.381 · 2019
New horizons of acute myocardial infarction: from the Korea Acute Myocardial Infarction Registry
10.3346/jkms.2013.28.2.173 · 2013
Third-generation P2Y12 inhibitors in East Asian acute myocardial infarction patients: a nationwide prospective multicentre study
10.1055/s-0038-1626697 · 2018
Clinical outcomes of adjusted-dose versus standard-dose prasugrel in East Asian patients with acute myocardial infarction
10.1016/j.ijcard.2024.132197 · 2024
Practical guidance for P2Y12 inhibitors in acute myocardial infarction undergoing percutaneous coronary intervention
10.1093/ehjcvp/pvaa005 · 2021
One-year clinical outcomes between single-versus multi-staged PCI for ST elevation myocardial infarction with multi-vessel coronary artery disease: from KAMIR-NIH
10.4070/kcj.2019.0176 · 2020
2021 Korean Society of Myocardial Infarction expert consensus document on revascularization for acute myocardial infarction
10.4070/kcj.2021.0043 · 2021
2024 Korean Society of myocardial Infarction/National Evidence-Based Healthcare Collaborating Agency guideline for the pharmacotherapy of acute coronary syndromes
10.4070/kcj.2024.0257 · 2024
No additional external references are available.